DISCOVER Magazine. Science, Technology and The Future
Current Issue
Subscribe Today »
  • Renew
  • Give a Gift
  • Archives
  • Customer Service
  • Facebook
  • Twitter
  • Newsletter
  • Health & Medicine
  • Mind & Brain
  • Technology
  • Space
  • Human Origins
  • Living World
  • Environment
  • Physics & Math
  • Video
  • Photos
  • Podcast
  • RSS
80beats
« Researchers Debate: Is It Preserved Dinosaur Tissue, or Bacterial Slime?
The “NASCAR of the Skies” Sends up Its First Rocket »

Breakthrough Alzheimer’s Therapy Slows Dementia in Real-World Study

neurons impulsesResearchers have tested a new pharmaceutical approach to combating Alzheimer’s, and say they may have found the breakthrough drug that can halt the progress of the disease. In a small clinical trial, researchers tested a drug that targets the tangles of protein that form in the brain cells of Alzheimer’s patients, and found that the drug stopped the cognitive decline of those patients.

Lead researcher Claude Wischik says: “This is an unprecedented result in the treatment of Alzheimer’s disease. We have demonstrated for the first time that it may [be] possible to arrest the progression of this disease by targeting the tangles which are highly correlated with the disease” [CNN]. The results were announced at the International Conference on Alzheimer’s Disease taking place in Chicago.

The researchers tested 321 patients with mild to moderate Alzheimer’s disease…. They evaluated the patients at intervals over seven years. “We’ve held the disease at bay for a total of 19 months [in the group that took the new drug], whereas the control group declined at the expected rate” [Reuters], says Wischik. Researchers caution that large-scale studies must be done to confirm the drug’s benefits, but say that if all goes well the drug could reach the market by 2012.

These results are of particular interest because they’re the first to show the efficacy of targeting the tangles made up of tau proteins. In the brain of a patient, protein molecules clump together to wreck the brain networks that hold memories, enable us to perform tasks or knit together when we learn something new, forming deposits of insoluble filaments and plaques. A major focus on research until now has focused on blocking the formation of plaques made from a molecule called beta amyloid [Telegraph]. But a recent study found that destroying those plaques had no impact on patients’ slide into dementia, and this new study seems to confirm that the plaques are a side effect of Alzheimer’s, rather than the cause.

Image: iStockphoto

Related Post: A Vaccine to Fight Alzheimer’s Fails, but an Allergy Medicine Shows Promise

Share

July 30th, 2008 9:48 AM Tags: Alzheimer's, dementia, pharmaceuticals
by Eliza Strickland in Health & Medicine, Mind & Brain | 1 comments | RSS feed | Trackback >

One Response to “Breakthrough Alzheimer’s Therapy Slows Dementia in Real-World Study”

  1. 1.   Andrew Carapiet Says:
    May 3rd, 2010 at 6:43 am

    What is this drug? What is its name and how can I get hold of this to help my mother?

    andrew@mfriendly.fsnet.co.uk

Leave a Reply





    • 80beats Daily Newsletter

      Enter your email address:

    • Twitter

      Follow @discovermag
    • Facebook

    • RSS Feed

      The RSS feed for 80beats is here RSS.

    • Sci News in 140

      rockahn.net
    • on 80beats

      Recent Comments

      Comments

      • LEE on Who Would Win in a (Legal) Fight: A Whale or a Battleship?
      • LEE on It’s a Small and Wonderful World: Stunning Images of Science Under the Microscope
      • Susan Durham on The Engineer Who Has “Saved More Lives Than Any Single Person in the History of Aviation”
      • Susan Durham on How Spider Silk’s Molecular Make-up Lets It Morph
      • Messier Tidy Upper on Who Would Win in a (Legal) Fight: A Whale or a Battleship?
      • Messier Tidy Upper on Solar Sleuthing Suggests When Odysseus Got Home: April 16, 1178 B.C.
      RSS Recent Posts

      Posts

      • To Escape Chinese Espionage, You Must Travel “Electronically Naked”
      • Why We Can’t Just Get Rid of the Genes That Let Us Get Infected
      • Cancer Drug Today, Alzheimer’s Drug Tomorrow? Hopeful Results in Mouse Study
      • Zebra Stripes: Fashion Statement or Fly Repellant?
      • Study: Americas + Europe + Asia Will Form Amasia, a Supercontinent in the Arctic
      Categories

      Categories

      • Environment
      • Feature
      • Health & Medicine
      • Human Origins
      • Journal Roundup
      • Living World
      • Mind & Brain
      • News Roundup
      • Photo Gallery
      • Physics & Math
      • Space
      • Technology
      • Top Posts
      • Uncategorized
      Archives

      Archives

      • February 2012
      • January 2012
      • December 2011
      • November 2011
      • October 2011
      • September 2011
      • August 2011
      • July 2011
      • June 2011
      • May 2011
      • April 2011
      • March 2011
      • February 2011
      • January 2011
      • December 2010
      • November 2010
      • October 2010
      • September 2010
      • August 2010
      • July 2010
      • June 2010
      • May 2010
      • April 2010
      • March 2010
      • February 2010
      • January 2010
      • December 2009
      • November 2009
      • October 2009
      • September 2009
      • August 2009
      • July 2009
      • June 2009
      • May 2009
      • April 2009
      • March 2009
      • February 2009
      • January 2009
      • December 2008
      • November 2008
      • October 2008
      • September 2008
      • August 2008
      • July 2008
      • June 2008
      • May 2008
    • About 80beats

      80beats is DISCOVER's news aggregator, weaving together the choicest tidbits from the best articles on the day's most compelling topics.

      80beats is written by Veronique Greenwood and Valerie Ross. This team darts through each day's science news faster than the ruby-throated hummingbird that beats its wings 80 times per second. Send ideas, tips, suggestions, and complaints to [azeeberg at discovermagazine dot com].



  • Kalmbach Publishing Co.

    Copyright © 2012, Kalmbach Publishing Co.

    Privacy - Terms - Reader Services - Subscribe Today - Advertise - About Us